Dillard R G, Crowe J E, Sumner T E
Am J Dis Child. 1980 Sep;134(9):821-3. doi: 10.1001/archpedi.1980.02130210005002.
Pancuronium bromide treatment in severely ill, mechanically ventilated infants has been shown to result in lower peak transpulmonary pressure, with an accompanying lower-than-expected incidence of pneumothorax. Infants, treated with pancuronium often demonstrate an ominous abdominal roentgenographic finding: the "gasless abdomen." Of 38 mechanically ventilated infants, 22 of 24 pancuronium-treated infants (as compared with four of 14 untreated infants) had diminished or absent bowel gas. There was no significant difference between the two groups with regard to birth weight, mortality, or incidence of respiratory distress syndrome. Pancuronium prevents swallowing of air but does not inhibit gut peristalsis, thus accounting for the evacuation of abdominal gas three hours or more after administration of the drug. Clinicians who treat infants with pancuronium should be aware of the phenomenon, to avoid needless roentgenographic studies.
在重症机械通气婴儿中使用溴化潘库溴铵治疗已显示可降低经肺峰值压力,同时气胸发生率低于预期。接受溴化潘库溴铵治疗的婴儿常出现不祥的腹部X线表现:“无气腹”。在38例机械通气婴儿中,24例接受溴化潘库溴铵治疗的婴儿中有22例(相比之下,14例未治疗婴儿中有4例)肠内气体减少或消失。两组在出生体重、死亡率或呼吸窘迫综合征发生率方面无显著差异。溴化潘库溴铵可防止空气吞咽,但不抑制肠道蠕动,因此在给药三小时或更长时间后可导致腹部气体排出。使用溴化潘库溴铵治疗婴儿的临床医生应了解这一现象,以避免不必要的X线检查。